Syntheses of the peptides with sequences postulated for active and inactive isomer of edeine D were carried out. The peptides obtained were identical with natural product in regard to chromatographic and electrophoretic properties. Biological data for synthesized compounds confirmed that in active and inactive isomer isoserine is linked with the a-or p-amino group of a, §-diaminopropionic acid, respectively.
also been found to be a useful tool for studying various aspects of ribosome function and protein synthesis7, [10] [11] [12] .
The ability of edeines to differentiate prokaryotic and eukaryotic microorganisms with regard to the inhibitory action on the biosynthesis of DNA13) points to the possibility of exploitation of differences in structure and functioning of DNA replicating apparatus in Prokaryota and Eukaryota as a molecular basis of selective toxicity in the search for chemotherapeutical agents.
The antibiotic complex formed during biosynthesis contains mainly four active compounds, edeines A, B, D and F. These antibiotics are pentapeptide amides composed of glycine, polyamine and four non-protein amino acids: a,(3-diaminopropionic acid, j3-phenyl-13-alanine or R-tyrosine, isoserine and 2,6-diamino-7-hydroxyazelaic acid2, [14] [15] [16] . Last three compounds have not previously been found to be components of naturally occurring peptides.
Edeines, similarly to a series of peptides and derivatives of a,,9-diaminopropionic acid17,18), undergo reversible intramolecular aminolysis in water solutions19). Such a reaction occurs during isolation and storage of the antibiotics. Thus, each of the edeines exists as a mixture of two isomeric peptides differing from one another by the mode of linkage of the a,~-diaminopropionic acid functional groups. The compounds in which isoserine is linked with the a-amino group of a,(3-diaminopropionic acid (a-isomers) were described as active isomers19). The p-isomers have been shown to be biologically inactive. The structural formulae of the a-isomers are presented in Fig. 1 .
We undertook the synthesis of the both edeine D isomers to demonstrate which is the active one.
Moreover, the synthesis was a confirmation for the postulated structure20)
Results
The general concept of the synthesis was based on the coupling of tripeptides corresponding to Table 1 .
As it is evident from Table 1, the two peptides do not differ in their chromatographic and elec- * Chromatography on silica gel GF25, plates (Merck) in the solvent systems:
1. 1-Butanol -pyridine -acetic acid -water, 6: 2: 3 : 5. 2. 1-Propanol -25% ammonia -chloroform, 12: 8 : 1. 3. 2-Propanol -25 % ammonia -water, 6: 4: 3. ** A buffer of pyridine -acetic acid -water , 10: 100: 890, pH 3.5 was used at 43 V/cm for 40 minutes.
The substances were visualized with ninhydrin reagent. *** Mixture of isomers . The protected a-isomer of edeine D (3, 175 mg, 0.13 mmol) was dissolved in a mixture of McOH (1.6 ml) and 4 N NaOH (0.4 ml) to hydrolyze the methyl ester. After 30 minutes the solution was added dropwise with cooling to 20 ml of 0.1 N HCI. The precipitate formed was filtered, washed with water, dried over P2O5 and crystallized from methanol -ethyl acetate mixture yielding 137.9 mg (79.6 %) of the compound 5; mp 178 180°C; FD-MS 1,307 (M+1)+, 1,306 (M+).
Anal The compound 5 (125 mg, 0.09 mmol) was dissolved in 98 % HCOOH (5 ml) and hydrogenolysis was performed in the presence of palladium black. After 5 hours the catalyst was filtered and washed with H2O. Next 0.1 N H2SO4 (3.6 ml) was added to the filtrate and the solvent evaporated to a small volume (1 ml). The concentrated solution was added dropwise to a mixture of MeOH (20 ml) and EtOH (5 ml) with stirring and centrifuged. The precipitate obtained was suspended in acetone -hexane (1: 1) solvent mixture and centrifuged. The operation was repeated in hexane and the product dried in vacuum yielding 79 mg (84.7 %) of the a-isomer of edeine D in the form of a white amorphous powder without defined melting point.
Anal 
